Alpine Immune Sciences Inc

NASDAQ:ALPN   3:59:53 PM EDT
8.07
+0.12 (+1.51%)
Earnings Announcements

Alpine Immune Sciences Reports First Quarter 2022 Results

Published: 05/12/2022 21:10 GMT
Alpine Immune Sciences Inc (ALPN) - Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2022 Financial Results.
Alpine Immune Sciences Inc- As of March 31, 2022, We Had Cash, Cash Equivalents, and Investments Totaling $219.1 Million.
Alpine Immune Sciences Inc- Expects That Its Current Cash Resources Will Be Sufficient to Fund Its Planned Operations Into 2024.
Alpine Immune Sciences Inc - Qtrly Loss per Share $0.25.
Alpine Immune Sciences Inc- Collaboration Revenue for Q1 Ended March 31, 2022 Was $13.6 Million Compared to $3.2 Million for Q1 Ended March 31, 2021.
Revenue is expected to be $10.04 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $18.71 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.